Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Treasury Shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative effect of adoption of ASU 2014-09 $ 2,221   $ 0   $ 2,221  
Beginning Balance (in shares) at Dec. 31, 2017   87,153       3,973
Beginning Balance at Dec. 31, 2017 501,875 $ 87 637,851 $ 243 (75,046) $ (61,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   7       241
Issuance of common stock 5,038 $ 0 5,038      
Issuance of restricted stock (in shares)   0       1,336
Issuance of restricted stock 0 $ 0 (1,303)     $ 1,303
Treasury stock purchase, at cost (in shares)           (257)
Treasury stock purchases, at cost (8,450)         $ (8,450)
Stock-based expense 10,410   10,410      
Interest rate swap agreements 258     258    
Foreign currency translation (127)     (127)    
Reclassification of realized gain on cash flow hedge to earnings, net of tax (99)     (99)    
Net income 10,901          
Ending Balance (in shares) at Mar. 31, 2018   87,160       2,653
Ending Balance at Mar. 31, 2018 $ 522,027 $ 87 $ 651,996 $ 275 $ (61,924) $ (68,407)